Ticker Scout
← tickerscout.ai

Unilever PLC (UL)

CIK 0000217410 · NYSE · Latest period: Q2 FY2026 (ended 2026-06-30, 6-K accession 0000217410-26-000057) · Annual report: FY2025 20-F (filed 2026-03-12, accession 0000217410-26-000007) · Next expected filing: 20-F ~2027-03-11

PeriodQ2 FY2026

Published

MetricAmountvs. year ago
Revenue$15,174,866,903up 6.5%
Underlying sales growth5.8%

Company details

NameUnilever Plc
TickerUL
CIK0000217410
ExchangeNYSE
CountryUnited Kingdom
SIC2840
OfficeIndustrial Applications and Services
IndustrySoap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Latest period coveredQ2 FY2026, ended 2026-06-30, 6-K, accession 0000217410-26-000057
Fiscal year end12/31 (MM/DD)
Next expected filing20-F around 2027-03-11 (predicted)

AI synthesis of three filings for Unilever PLC

Unilever reports in euros. Every money amount on this page has been converted to US dollars: amounts for a period use that period's average exchange rate (Unilever's own published average where it gives one), while balances and amounts tied to a single date, such as a deal price, use the rate on that date. Percentage changes are the company's own, measured in euros or on its underlying basis, unless a sentence marks a change as being in US dollar terms. Per-share amounts are per Unilever PLC ordinary share. Figures for 2025, including the 2025 comparatives in the half-year report, exclude the Ice Cream business, which Unilever demerged in December 2025.

Business

Source: Annual Report on Form 20-F 2025 (fiscal year ended 31 December 2025), accession 0000217410-26-000007.

Unilever sells branded everyday consumer products: shampoo and skin care, prestige beauty and wellbeing supplements, deodorants, soap and body wash, toothpaste, laundry detergents and household cleaners, and soups, bouillons, seasonings and mayonnaise. Its products are sold in about 190 countries, and the company says 3.7 billion people use them every day. Revenue ("turnover") is the value of goods sold to retail and distributor customers, including through digital commerce, and to food-service operators, after discounts, rebates and other customer incentives. No single customer accounts for 10% or more of turnover. In 2025 the company had turnover of $56.77 billion, about 96,000 employees and $939.66 million of research and development spending.

The business is organised into four Business Groups, which are its reporting segments. They are similar in size; 2025 turnover and underlying operating profit for each were:

  • Beauty & Wellbeing: hair care, skin care, prestige beauty and wellbeing (vitamins, minerals and supplements). Turnover was $14.44 billion and underlying operating profit $2.78 billion. Its Power Brands are Dove, Sunsilk, TRESemmé, Clear, Nexxus, Vaseline, Pond's, Dermalogica, Hourglass, K18, Paula's Choice, Liquid I.V., Nutrafol and OLLY.
  • Personal Care: deodorants, skin cleansing and oral care. Turnover was $14.79 billion and underlying operating profit $3.34 billion. Its brands include Dove, Rexona, Axe, Lux, Lifebuoy, Closeup and Pepsodent.
  • Home Care: fabric cleaning, fabric enhancers and home and hygiene products. Turnover was $13.00 billion and underlying operating profit $1.93 billion. Its brands include Dirt Is Good, Surf, Comfort, Cif, Domestos, Sunlight and Radiant.
  • Foods: cooking aids and mini-meals, condiments, and Unilever Food Solutions (food service). Turnover was $14.53 billion and underlying operating profit $3.28 billion. Its Power Brands are Knorr, Hellmann's and Horlicks.

By category, fabric products were the largest part of 2025 turnover at 17%. Hair care, skin cleansing and cooking aids were each 12%, deodorant 11%, condiments and skin care each 8%, and home and hygiene 5%. Power Brands made up 78% of turnover.

Emerging markets produced 59% of 2025 turnover. By region, Asia Pacific Africa was the largest, followed by the Americas and then Europe. The United States is the biggest single market, with turnover of $11.80 billion, followed by India at $6.99 billion, where the business operates through Hindustan Unilever. The top 24 markets account for about 85% of turnover. The remaining small and mid-sized markets are grouped under "One Unilever" and each manages its own profit and loss.

The strategy rests on three shifts. "Desire at Scale" means premium, science-led brands supported by social-first marketing and strong in-store and online execution. "Play to Win" is a performance culture. The third is an organisation "Fit for the AI Age". Alongside these, the company has named seven growth priorities: Beauty, Wellbeing, Personal Care, premium products, digital commerce, and its two anchor markets, the United States and India. Its medium-term financial framework has these parts:

  • underlying sales growth of 4% to 6% a year, with at least 2% from volume
  • a modest improvement in underlying operating margin, funded by gross margin
  • cash conversion of about 100%
  • net debt of about 2x underlying EBITDA and strong single-A credit ratings
  • a dividend payout ratio of about 60%, with surplus cash returned through buybacks
  • bolt-on acquisitions rather than transformational deals

The portfolio has been reshaped heavily. On 6 December 2025 Unilever completed the demerger of its Ice Cream business as The Magnum Ice Cream Company N.V. (TMICC), which is listed in Amsterdam, London and New York. Unilever kept a 19.85% stake, which it plans to sell down in an orderly way to pay demerger costs. Alongside the demerger, shareholders received 8 new shares for every 9 they held on 8 December 2025. In 2025 the company also made bolt-on acquisitions, including Dr. Squatch in North America, Minimalist in India and Wild in western markets, and sold non-core, mostly Foods brands. These included Conimex and The Vegetarian Butcher, and agreements were reached to sell Graze, Unox and Zwan. In March 2026, after the annual report was filed, Unilever agreed to combine its Foods business with McCormick & Company. If that deal completes, Unilever will be a pure-play home and personal care company built on Beauty & Wellbeing, Personal Care and Home Care (see Current period).

Risk factors

Source: "Our Principal Risks", Form 20-F 2025, accession 0000217410-26-000007. The half-year report of 28 July 2026 (accession 0000217410-26-000057) says the nature and potential impact of the principal risks are essentially unchanged for the second half of 2026.

The company rates three risks as higher than a year earlier: information and cyber security, economic and geopolitical risk, and portfolio management. It rates business transformation risk as lower now that the Ice Cream demerger is complete. It merged several risks for 2025 and no longer treats treasury and tax as a principal risk.

  • Consumer and channel. Demand depends on brands staying relevant while shopping shifts fast toward digital commerce and new retail formats. If Unilever misreads these changes, it could lose brand equity and market share.
  • Portfolio management (increased). Growth and margins depend on where capital is allocated across Business Groups, markets and channels. Shifting consumer preferences, changing channels and economic uncertainty make these choices harder to get right and to carry out.
  • Economic and geopolitical (increased). More than half of turnover comes from emerging markets, which exposes the company to currency swings, price controls and political instability. Armed conflict, protectionism and tariffs add to the risk. Currency is a recurring drag: it reduced reported turnover by 5.9% in 2025 and by 4.9% in the first half of 2026. A large cash shortfall could hurt the credit rating and access to funding.
  • Information and cyber security (increased). The company depends on secure IT systems and relies more and more on third parties. Attackers are using AI to automate phishing and deepfake social engineering. Past attacks have not had a material impact, but a major incident could disrupt sales, supply chain and cash flow.
  • Business operations. Geopolitical tension, trade restrictions, tariffs or problems at a key supplier could disrupt supply. Changes in commodity and material costs cannot always be passed on in prices. Commodity inflation cut gross margin in the first half of 2026.
  • Climate and nature. Extreme weather can disrupt sourcing, factories and distribution. Carbon pricing, land-use rules and limits on greenhouse-gas-intensive ingredients could raise costs. Scarce water could constrain operations and reduce demand for products that need water to use.
  • Plastic packaging. Rules such as extended producer responsibility schemes and packaging bans raise costs and compliance demands. New packaging formats must not compromise product performance or safety.
  • Safe, high-quality products. Contamination, product defects or labelling errors could harm consumers and the brands. Changing rules on ingredients and nutrition could restrict sales in some markets.
  • Talent. The new operating model depends on attracting and keeping people with the right skills and on building a high-performance culture quickly.
  • Business transformation (decreased). Unilever is starting a major programme to simplify core processes, modernise its digital foundations and use generative AI. Poor design choices could build in complexity and raise long-term costs, and greater use of AI brings operational, reputational and compliance risks.
  • Legal and compliance. Unilever is subject to laws on product safety, competition, anti-bribery, sanctions, data privacy, environmental reporting and human-rights due diligence. Breaches could bring fines, enforcement action and reputational damage.
  • Pending Foods–McCormick transaction. The half-year report names the risks that the deal may not close on the expected terms or timetable, or at all, and that the combined company may not deliver the expected synergies.

Contingent liabilities. At 31 December 2025 Unilever disclosed $5.86 billion of contingent liabilities, of which $5.28 billion related to Brazilian tax matters. The largest, about $4.17 billion, comes from tax assessments challenging a 2001 corporate reorganisation in Brazil. The original 2004 notice over that reorganisation was resolved in the courts in Unilever's favour, but a new assessment was raised in 2013, and further notices on the same grounds followed in 2014 and between 2017 and 2025. The group also faces litigation over alleged asbestos contamination in talcum powder products made and sold decades ago; provisions are made where a settlement is probable and can be estimated. Separately, non-underlying items in the 2026 half-year results include a charge for settlements reached with plaintiff law firms, and an estimate for possible future claims, over products the group no longer makes or sells.

Management's discussion of 2025

Source: Strategic Report and Group Financial Review, Form 20-F 2025, accession 0000217410-26-000007.

Turnover was $56.77 billion, down 3.8% in euro terms and 0.3% in US dollar terms. Underlying sales growth (USG) of 3.5% was more than offset by currency (−5.9%) and net disposals (−1.2%). The currency drag came mainly from Latin American currencies, the Indian rupee, the US dollar and the Turkish lira, all of which weakened against the euro. USG was made up of 1.5% volume and 2.0% price, and the company has now reported 12 consecutive quarters of volume growth. Power Brands grew 4.3%, with 2.2% from volume.

  • Beauty & Wellbeing: USG 4.3% (2.2% volume). Wellbeing (Nutrafol, Liquid I.V.), Vaseline and Dove grew double-digit, while price execution problems held back volume in the Americas. Underlying operating margin fell 20 basis points to 19.2% as heavier brand investment absorbed overhead savings.
  • Personal Care: USG 4.7%, mostly price (3.6%), helped by premium innovation such as whole-body deodorants and commodity-driven price rises. Underlying operating margin rose 50 basis points to 22.6%.
  • Home Care: USG 2.6%, driven by volume (2.2%, rising to 4.0% in the fourth quarter). Liquid detergents, including Wonder Wash, grew double-digit, while powders declined in Brazil and South Africa. Underlying operating margin rose 40 basis points to 14.9%.
  • Foods: USG 2.5% (0.8% volume), led by emerging markets while developed markets declined. Underlying operating margin rose 130 basis points to 22.6%.

By market, developed markets (41% of turnover) grew 3.6%. North America grew 5.3% and Europe 1.5%. Emerging markets grew 3.5%: India 4.0%, Indonesia 4.0%, China flat, and Latin America only 0.5% as price rises were largely offset by lower volumes. The Chair called it a disappointing year for Latin America, which required corrective pricing action and changes to format mix.

Gross margin rose 20 basis points to 46.9%, helped by supply-chain savings, volume leverage and mix. Brand and marketing investment rose to 16.1% of turnover, and overheads fell 50 basis points as a share of turnover because of the productivity programme. Underlying operating margin rose 60 basis points to 20.0%. Underlying operating profit was $11.33 billion, down 1.1% in euro terms because of currency. Reported operating profit rose 2.4% in euro terms to $10.16 billion, helped by lower restructuring costs and smaller losses on disposals. Net profit was $6.98 billion. Diluted EPS was $2.91, up 6.2% in euro terms. Underlying EPS was $3.46, up 0.7% in euro terms after an 8.8% currency drag. Underlying return on invested capital was 19.0%.

Free cash flow was $6.66 billion, down 6.1% in euro terms and 2.7% in US dollar terms. Taxes linked to the Ice Cream demerger more than offset better working capital, and cash conversion was 100%. Unilever returned $6.70 billion to shareholders: $5.01 billion in dividends and $1.70 billion in share buybacks. The Ice Cream business is reported as a discontinued operation. Up to the demerger it had turnover of $8.64 billion, and the discontinued profit after tax of $4.27 billion mainly reflects the gain on the demerger.

In the annual report the company guided to 2026 underlying sales growth at the bottom end of its 4% to 6% range, with at least 2% volume growth and a modest improvement in underlying operating margin.

Current period: first half and second quarter of 2026

Source: 2026 First Half Results, Form 6-K furnished 28 July 2026 for the period ended 30 June 2026, accession 0000217410-26-000057.

Growth accelerated and was driven by volume. First-half USG was 4.8%: 4.2% from volume and 0.6% from price. In the second quarter USG rose to 5.8%, with 5.5% from volume, which the CEO called Unilever's best volume quarter in more than a decade. Power Brands grew 6.0%, with 5.4% from volume. First-half turnover was $29.90 billion, up 0.5% in euro terms and 7.8% in US dollar terms. Net acquisitions added 0.7% and currency took off 4.9%. Second-quarter turnover was $15.17 billion, up 3.8% in euro terms, with a smaller currency drag of 2.4%. Second-quarter price growth was only 0.2%, held down by three factors the company calls temporary: tough Personal Care price comparisons, planned FIFA World Cup 2026 promotions, and the carryover of 2025 Home Care actions to restore competitive price gaps in Brazil. Management expects pricing to pick up in the second half as commodity-driven price rises take effect.

The company gave the following first-half results by Business Group, with USG for the half and for the second quarter:

  • Beauty & Wellbeing: first-half USG 5.9% (4.5% volume) and second quarter 8.1%. Dove, Sunsilk and Vaseline grew double-digit, K18 grew strongly, and Paula's Choice, Hourglass and Tatcha accelerated. Wellbeing grew only low-single digit; Nutrafol is working to win new customers, including by positioning it alongside GLP-1 treatments. Underlying operating margin was 19.5%, up 10 basis points. Second-quarter turnover was $3.96 billion.
  • Personal Care: first-half USG 4.8% (4.1% volume) and second quarter 5.9%, with price down 0.9% in the quarter because of World Cup promotions and tough comparisons. Deodorants and skin cleansing grew mid-single digit, and US deodorants regained market leadership. Underlying operating margin was 22.2%, up 10 basis points. Second-quarter turnover was $4.11 billion.
  • Home Care: first-half USG 7.6% (7.4% volume) and second quarter 9.1%. India grew double-digit and reached its highest-ever Home Care share, and Brazil grew high-single digit. Commodity and currency pressure lowered gross margin, but underlying operating margin still rose 30 basis points to 15.8%. Second-quarter turnover was $3.5 billion.
  • Foods: first-half USG 1.2% and second quarter only 0.2%, below the company's expectations. Developed markets were soft and Unilever lost share in the premium and avocado segments of US mayonnaise; India, helped by Horlicks, and Unilever Food Solutions grew. Underlying operating margin was flat at 23.3%, and underlying operating profit fell 4.3% in euro terms. Second-quarter turnover was $3.60 billion.

Emerging markets (60% of turnover) grew 7.0%, and 8.3% in the second quarter. India grew 8% (10% in the second quarter), Indonesia 7%, China mid-single digit and Latin America 7.6%. Brazil returned to strong, volume-led growth after corrective actions taken last year, and Argentina grew strong double-digit. Developed markets grew 1.5%. North America grew 2.7% (3.6% in the second quarter), ahead of its market, while Europe fell 0.9%, with declines in Germany and Eastern Europe.

Margins and earnings. Underlying operating profit was $6.06 billion, up 0.9% in euro terms, and underlying operating margin rose 10 basis points to 20.3%. Gross margin fell 70 basis points to 46.8% because of commodity inflation, deliberately measured pricing and the World Cup promotions. That was offset by brand and marketing investment slipping 10 basis points to 16.1% of turnover and by overheads falling 70 basis points. The company finished its productivity programme ahead of schedule. Launched in 2024 and sized at $913.36 million at the 30 June 2026 exchange rate, it was designed to simplify the business and remove overheads left behind by the Ice Cream demerger. Reported operating profit was $5.70 billion, up 2.6% in euro terms, helped by restructuring costs falling to $152.88 million.

Non-underlying costs also included $114.37 million for separating the Foods business. Net finance costs were $352.43 million, or 2.5% of average net debt. The reported tax rate rose to 30.3% from 26.3% because of tax effects from the 2025 Ice Cream separation, while the underlying rate was 26.0%. Net profit from continuing operations was $3.84 billion, down 3.5% in euro terms. Diluted EPS from continuing operations was $1.61, down 2.5% in euro terms. Underlying EPS was $1.88, up 2.4% in euro terms despite a 6.0% currency drag; the buyback added 0.7%. Discontinued operations included a $348.93 million gain on selling the remaining Indian and Portuguese ice cream businesses to TMICC.

Cash and balance sheet. Free cash flow was $1.81 billion, up 42.9% in euro terms and 53.3% in US dollar terms, thanks to slightly higher operating profit and better working capital, partly offset by higher tax payments and capital spending. Net debt was $29.64 billion at 30 June 2026, compared with $27.08 billion at 31 December 2025. The increase reflects dividends and the buyback, and net debt was 2.3x underlying EBITDA. Cash was $5.40 billion. Unilever had undrawn 364-day bilateral revolving credit facilities of $5.2 billion and $2.97 billion, and it signed a further $2.28 billion of such facilities in June. A $591.1 million 0.750% note matured and was repaid in February. The pension plans were in surplus by $4.28 billion.

Capital returns. The second-quarter dividend is the same per share as the first quarter's and up 3.0% on a year earlier; the company states it as $0.5305 per American Depositary Receipt. The $1.75 billion buyback ran from 30 April to 5 June 2026 and bought back 30,703,780 shares. Unilever expects cash from the Foods separation plus operating performance to fund $6.91 billion of buybacks in total over 2026–2029, at the exchange rate on the 31 March 2026 announcement date.

Portfolio moves in the first half. The company describes its first-half deals as aimed at its priority growth areas and at focusing on fewer, bigger and more scalable brands. On 1 June Unilever bought 80% of Grüns Nutrition, a fast-growing US greens-supplement company, for $891.56 million, with provisional net assets of about $569.58 million, and recorded a liability for buying out the remaining 20%. Hindustan Unilever bought the remaining 49% of OZiva, a plant-based wellness brand. Disposals, for which no prices were disclosed, were Graze in the UK, the SariWangi tea business in Indonesia, the Central America and Caribbean Home Care business, and the 99.8% stake in Unilever Côte d'Ivoire. On 1 April the Indian (Kwality Wall's) and Portuguese ice cream businesses, whose transfer had been delayed at the demerger, were sold to TMICC. Sales of the Colombia and Ecuador laundry businesses, agreed in January 2026, are expected to close during 2026.

Foods combination with McCormick. In March 2026 Unilever agreed to combine its Foods business with McCormick & Company to create a global flavour company. This would leave Unilever as a pure-play home and personal care company. The financial terms were published in the 31 March 2026 announcement furnished on Form 6-K (accession 0000217410-26-000019). According to that filing, McCormick will file a registration statement on Form S-4 including its proxy statement, and a Unilever Foods entity will file a Form 10 registration statement for the spin-off of Unilever Foods from Unilever. Teams are working on carve-out financials, tax, antitrust, synergies and integration. Completion is expected by mid-2027 at the latest, subject to McCormick shareholder approval, regulatory approvals and other customary conditions, and works-council consultation must be completed first.

Outlook (upgraded). For 2026, Unilever now expects:

  • underlying sales growth within its 4% to 6% range with about 3% volume growth, up from the earlier guidance of the bottom end of the range with at least 2% volume
  • second-half underlying sales growth of 4% to 5%, led by pricing
  • a modest improvement in underlying operating margin from 20.0%
  • second-half gross margin broadly similar to the first half
  • an underlying tax rate of about 26%
  • net finance costs below 3% of average net debt
  • restructuring costs of about 1% of turnover
  • cash conversion of about 100%
  • net debt of about 2x underlying EBITDA

The company warned that Brazilian tax reforms, expected to lower prices from the start of 2027, may lead some retailers to cut stock temporarily in the fourth quarter.

Subsequent events

Source: note 11 and the narrative sections of the half-year report, accession 0000217410-26-000057.

The half-year report says there were no material events after 30 June 2026 other than those it describes elsewhere. Those are:

  • McCormick update (23 July 2026). McCormick announced the planned operating model and executive team of the combined flavour company, and London as its secondary listing location. The transaction remains pending.
  • Second-quarter dividend. The Board declared the dividend, $0.5305 per ADR as stated by the company, on 28 July 2026. The ADR ex-dividend date was 7 August, the record date 7 August, and payment was due on 18 September 2026.
  • Pending disposals. The sales of the Colombia and Ecuador laundry businesses had not closed by the report date and are expected to complete during 2026.
  • Upcoming dates. The third-quarter dividend announcement and trading statement are scheduled for 28 October 2026, with the dividend payable on 18 December 2026. An investor event is planned in New York on 4 November 2026.

The report identifies no acquisition, disposal or financing completed between 30 June 2026 and its 28 July 2026 date.

AI synthesis of events in 15 filings

Unilever reports in euros. Amounts below are converted from euros to US dollars, using the average rate for the period for flows and the closing rate for balances. Percentages and per-share ratios the company states without an amount are given as the company states them.

Filings that contain financial statements

  • Form 6-K filed 28 July 2026, accession 0000217410-26-000057: the first-half 2026 results for the six months ended 30 June 2026, with comparatives for the first half of 2025 re-presented for the Ice Cream demerger. It holds condensed consolidated interim financial statements (unaudited): the income statement, statement of comprehensive income, statement of changes in equity, balance sheet and cash flow statement, with notes (including demerger, acquisitions and disposals, share buyback, dividends, financial instruments and post-balance-sheet events), plus segment tables, second-quarter growth figures and non-GAAP reconciliations.
  • Form 20-F filed 12 March 2026, accession 0000217410-26-000007: the annual report for the year ended 31 December 2025 (audited).
  • Form 6-K filed 12 February 2026, accession 0001654954-26-001155: 2025 full-year results release, with the year's financial statements.
  • The first-quarter 2026 trading statement furnished in the Form 6-K filed 30 April 2026 (accession 0000217410-26-000034) is attached as a graphic-only exhibit.

No other 6-K in this period carries financial statements.

First-half 2026 results (6-K, 28 July 2026, accession 0000217410-26-000057)

  • First-half turnover was $29.90 billion (EUR 25,623 million), up 0.5% in euro terms. Underlying sales growth was 4.8% (4.2% volume, 0.6% price). Second-quarter turnover was $15.17 billion (EUR 13,046 million), up 3.8% in euro terms, with underlying sales growth accelerating to 5.8% (5.5% volume). Currency was a (4.9)% drag on the half and (2.4)% in the quarter.
  • Underlying operating profit was $6.06 billion (EUR 5,193 million), up 0.9% in euro terms; underlying operating margin was 20.3%, up 10bps. Gross margin was 46.8% (down 70bps) and brand and marketing investment 16.1% of turnover. Net profit from continuing operations was $3.84 billion (EUR 3,291 million), down 3.5% in euro terms. Underlying EPS rose 2.4% in euro terms to $1.88 (EUR 1.61); diluted EPS from continuing operations fell 2.5% in euro terms to $1.61 (EUR 1.38). Free cash flow was $1.81 billion (EUR 1,549 million against EUR 1,084 million), up 42.9% in euro terms.
  • Business groups, first-half underlying sales growth: Beauty & Wellbeing 5.9%, Personal Care 4.8%, Home Care 7.6%, Foods 1.2%. Foods turnover fell (4.0)%, with developed-market weakness and share loss in US condiments cited.
  • Outlook upgraded: full-year 2026 underlying sales growth within the 4% to 6% multi-year range, with around 3% underlying volume growth; second-half underlying sales growth of 4% to 5%, led by price; a modest improvement in full-year underlying operating margin versus 20.0% in 2025.
  • Net debt was $29.64 billion (EUR 25,961 million) at 30 June 2026, against $27.08 billion (EUR 23,076 million) at 31 December 2025; net debt to underlying EBITDA was 2.3x. The company attributes the rise to dividends paid and the share buyback.
  • The $913.36 million (EUR 800 million) productivity programme launched in 2024 was reported completed ahead of schedule. First-half non-underlying items within operating profit were a net charge of $359.44 million (EUR 308 million), including restructuring costs of $152.88 million (EUR 131 million) and acquisition and disposal costs of $210.06 million (EUR 180 million), of which $114.37 million (EUR 98 million) for the Foods separation.

Unilever Foods combination with McCormick

  • Signed, not closed. The 6-K states that in March 2026 Unilever "announced an agreement to combine Unilever's Foods business with McCormick". Before that, a 20 March 2026 6-K (accession 0001654954-26-002527) confirmed Unilever had "received an inbound offer for its Foods business" and was in discussions with McCormick & Company, Inc. A 31 March 2026 6-K (accession 0000217410-26-000019) furnished the transaction announcement as a graphic-only exhibit, which does not set out the deal terms in text; it carries the standard notice that McCormick intends to file a Form S-4 registration statement with the SEC.
  • Status per the 28 July 2026 6-K: separation and integration workstreams (carve-out financials, tax, antitrust, synergies) are under way. McCormick announced the combined company's planned operating model, executive team and a London secondary listing on 23 July 2026. Completion is expected "by mid-2027 at the latest", subject to McCormick shareholder approval, regulatory approvals and customary conditions; Works Council consultation is under way.
  • The company says the transaction would leave Unilever a pure-play home, personal care and beauty business. It also states that cash receipts from the separation plus operating performance are expected to support EUR 6 billion ($6.91 billion) of share buybacks across 2026 to 2029.

Capital returns

  • Share buyback: on 30 April 2026 Unilever began a buyback of up to EUR 1.5 billion (6-K, accession 0001654954-26-004088), first set out with the 2025 full-year results. Completion was announced on 5 June 2026: 30,703,780 shares were bought for $1.75 billion (EUR 1.5 billion), held in treasury (6-K filed 1 July 2026, accession 0000217410-26-000040). Treasury shares were 30,703,780 of 2,185,205,247 issued at 31 July and 31 August 2026 (accessions 0001654954-26-007194 and 0001654954-26-008017), against none at 31 March and 30 April 2026.
  • Dividend: the second-quarter 2026 dividend is EUR 0.4664 per share (US$0.5305 per ADR, as the company states it), unchanged from the first quarter and up 3.0% on the second quarter of 2025. Ex-dividend date for ordinary shares 6 August 2026 and payment 18 September 2026; the third-quarter dividend is to be announced on 28 October 2026 (accession 0000217410-26-000057).

Acquisitions and disposals (all closed unless stated)

  • Closed 1 June 2026: Unilever acquired 80% of Grüns Nutrition Inc., a US vitamins, minerals and supplements company in greens supplements, for $891.56 million (EUR 767 million), with provisional net assets of about $569.58 million (EUR 490 million). A liability was recognised for the future buyout of the remaining non-controlling interest (accession 0000217410-26-000057, note 7).
  • Closed in the half: sale of Graze (2 February); acquisition of the remaining 49% of OZiva by Hindustan Unilever (12 February); sale of the Indonesian tea business (2 March); sale of the Central America and Caribbean Home Care business (16 March); sale of Unilever Cote d'Ivoire (23 March); sale of the 61.9% Kwality Wall's (India) stake and the 55% Portuguese ice cream joint venture to The Magnum Ice Cream Company (both 1 April; the gain of $348.93 million (EUR 299 million) is in discontinued operations).
  • Signed, not closed: the January 2026 agreements to sell the Home Care businesses in Colombia and Ecuador, expected to close during 2026.
  • Ice Cream: the demerger of the Ice Cream business (now The Magnum Ice Cream Company N.V.) completed on 6 December 2025; Unilever retains a 19.85% stake, held as an equity investment.

Governance

  • 13 May 2026 annual general meeting (accession 0001654954-26-004811): all resolutions passed. Srinivas Phatak was elected a director and the other nine directors standing were re-elected; the Directors' Remuneration Policy received 95.69% of votes cast in favour and KPMG LLP was reappointed auditor.
  • 28 July 2026 (accession 0000217410-26-000057): Belen Garijo Lopez told Unilever she will not take up her planned independent non-executive director role, expected from 2027, following her appointment as CEO of Sanofi in May 2026.

Debt

  • 15 May 2026 (accession 0001654954-26-004985): an updated Information Memorandum was published for the $25 billion Debt Issuance Programme of Unilever Finance Netherlands B.V., Unilever Capital Corporation and Unilever PLC. The filing does not report a specific issuance.

Routine filings

Monthly voting-rights and capital notices and director and executive share-transaction notices were also filed from April to September 2026. Examples are a sale of 15,643 ADRs by the Personal Care business group president on 21 August 2026 (accession 0001654954-26-007828) and dividend-reinvestment purchases by the CFO and other executives (for instance accessions 0001654954-26-006503 and 0001654954-26-008570). None reports a change in strategy or outlook.

Not set out in the filings listed

  • The terms of the McCormick transaction (consideration, ownership split) are not set out in the text of the filings listed above.
  • Third-quarter 2026 results are scheduled for 28 October 2026 and an investor event for 4 November 2026; neither has been filed.

Financials

Figures link to the filing they came from. Wherever the SEC filing tags a number, that number is linked: click it and the filing opens at the exact line that prints it. A figure with no link was either derived by AI, such as a margin, free cash flow or a trailing-twelve-month total, or taken from a filing that does not tag its numbers, such as an earnings release.

About this file

TickerUL
CIK0000217410
CompanyUnilever PLC
Business typeindustrial
Schema templatestandard (consumer goods, IFRS): turnover, operating profit, profit from continuing and discontinued operations, EPS; balance sheet; cash flow; business-group and geographic turnover; Unilever's own underlying (non-GAAP) measures kept in a separate block
Reporting currencyEUR
Converted to USDyes
Unitsactual US dollars (not millions), converted from euros; per-share figures are per American Depositary Share, which represents one ordinary share; share counts are ordinary share units as filed; growth rates and margins are percent

UL annual income statement, balance sheet and cash flow

Taken from the SEC filings, converted to US dollars and normalized to actual dollars.

FY2025FY2024FY2023
Period start2025-01-012024-01-012023-01-01
Period end2025-12-312024-12-312023-12-31
Period typefiscal yearfiscal yearfiscal year
Source accession20-F20-F20-F
Income statement
Revenue56,765,353,83556,939,714,14655,900,244,888
Cost of sales30,116,446,36330,353,959,54531,562,870,469
Gross profit26,648,907,47226,585,754,60124,337,374,419
Selling and administrative expenses15,313,371,10015,520,924,76714,516,973,426
Operating income10,157,584,7509,579,464,8569,732,786,445
Net finance costs565,371,819564,199,992442,399,384
Net monetary loss from hyperinflationary economies76,431,976218,084,997182,800,723
Share of net profit of joint ventures and associates275,379,912271,249,996246,618,727
Other income from non current investments and associates-19,107,99414,105,000-23,796,544
Profit before tax9,770,928,8739,082,534,8649,331,490,183
Income tax expense2,788,643,1082,530,219,9622,152,505,560
Net income from continuing operations6,983,409,7656,552,314,9027,178,984,623
Net income from discontinued operations4,268,950,634358,049,995544,075,526
Net income11,252,360,3996,910,364,8967,723,060,149
Net income attributable to noncontrolling interests609,207,805678,124,990706,324,689
Net income attributable to shareholders10,643,152,5946,232,239,9077,016,735,460
Net income from continuing operations attributable to shareholders6,386,565,9565,891,549,9126,492,129,834
Basic EPS4.86692.81013.1368
Diluted EPS4.85572.79933.1260
Diluted EPS continuing operations2.91122.64742.8880
Basic weighted average shares2,184,000,0002,215,600,0002,236,400,000
Diluted shares2,195,300,0002,228,500,0002,251,000,000
Balance sheet
Goodwill20,783,284,17923,094,121,666
Intangible assets20,015,749,71319,242,513,637
Property plant and equipment10,553,012,10312,078,584,811
Total non current assets62,676,113,36562,681,530,706
Inventories4,744,865,2065,358,713,991
Trade and other current receivables8,621,266,3386,221,987,599
Cash and cash equivalents4,625,157,9966,351,375,131
Other current financial assets1,315,605,7131,376,683,332
Total current assets20,028,659,31419,867,714,188
Total assets82,704,772,68082,549,244,894
Current financial liabilities3,030,235,4597,232,245,443
Trade payables and other current liabilities19,879,612,10217,275,823,163
Total current liabilities25,422,525,37626,119,719,695
Non current financial liabilities30,156,828,18125,945,822,853
Total non current liabilities36,642,142,33733,082,839,073
Total liabilities62,064,667,71359,202,558,768
Shareholders equity18,226,009,56020,691,653,987
Noncontrolling interests2,414,095,4072,655,032,140
Total equity20,640,104,96723,346,686,127
Total financial liabilities33,187,063,64133,178,068,296
Cash flow
Depreciation amortisation and impairment1,520,771,5131,486,449,9781,241,746,926
Changes in working capital130,383,958-203,979,997814,490,797
Cash flow from continuing operating activities before tax12,107,724,12611,840,604,82211,169,232,367
Income tax paid continuing operations-3,057,279,022-2,660,419,960-2,090,850,878
Operating cash flow9,050,445,1049,180,184,8629,078,381,489
Total cash flows from operating activities9,385,396,99710,328,114,84510,195,737,390
Purchase of intangible assets-195,575,937-252,804,996-260,680,322
Capex-1,592,707,490-1,498,384,978-1,291,503,336
Acquisition of businesses and investments in joint ventures and associates-1,881,575,398-796,389,988-108,166,109
Net cash used in continuing investing activities-2,690,855,139-458,954,993-1,526,223,791
Total net cash used in investing activities-3,504,630,879-678,124,990-2,481,330,530
Dividends paid on ordinary shares-5,005,170,398-4,686,114,930-4,719,287,315
Repurchase of shares-1,697,239,457-1,636,179,975-1,630,063,256
Net cash used in continuing financing activities-11,109,612,445-7,409,464,889-7,662,487,128
Total net cash used in financing activities-7,658,933,549-7,530,984,887-7,780,388,187
Non GAAP
Underlying operating profit11,334,412,37311,064,829,8349,820,400,993
Underlying EPS diluted3.46193.32012.9205
Free cash flow as defined by unilever6,655,201,8706,839,839,8976,971,305,695
Net debt27,081,995,91825,379,623,016
Segments by business group
Beauty and wellbeing
Revenue14,441,147,37914,275,344,78613,483,987,089
Operating income2,334,547,2532,137,449,9682,389,389,337
Underlying operating profit2,777,403,1112,768,919,9582,521,351,990
Personal care
Revenue14,792,959,26614,775,529,77814,958,291,149
Operating income3,034,799,0292,971,814,9553,198,471,829
Underlying operating profit3,341,650,9313,270,189,9513,019,997,750
Home care
Revenue12,999,055,84013,401,919,79913,175,713,680
Operating income1,699,487,4561,650,284,9751,534,877,080
Underlying operating profit1,931,031,3821,936,724,9711,618,164,984
Foods
Revenue14,532,191,35014,486,919,78314,282,252,970
Operating income3,088,751,0122,819,914,9582,610,048,199
Underlying operating profit3,284,326,9493,088,994,9542,660,886,270
Revenue by geographic area
Asia pacific africa25,207,939,93325,441,079,61825,748,942,135
The americas20,931,121,30221,271,424,68120,334,146,742
Europe10,626,292,60010,227,209,8479,817,156,010
Conversion
CurrencyEUREUREUR
Average
Eur per USD0.889680.9216590.924504
Ads ratio1.01.01.0
Closing
Eur per USD0.8520790.96609
SourceFRED DEXUSEU, rate on 2025-12-31FRED DEXUSEU, rate on 2024-12-31
  • Accounting basis. IFRS as issued by the IASB and UK-adopted international accounting standards (audited, Form 20-F)
  • Conversion: average source, FY2025. FY2025 Form 20-F (accession 0000217410-26-000007), exchange-rate table in the non-GAAP measures section: 'US dollar (EUR1 = US$) | 1.124 | 1.085' annual average rate in 2025; expressed here as euros per US dollar (1/1.124)
  • Conversion: average source, FY2024. FY2025 Form 20-F (accession 0000217410-26-000007), exchange-rate table in the non-GAAP measures section: 'US dollar (EUR1 = US$) | 1.124 | 1.085' annual average rate in 2024; expressed here as euros per US dollar (1/1.085)
  • Conversion: average source, FY2023. FRED DEXUSEU, average of 249 daily rates 2023-01-01 to 2023-12-31

UL quarterly income statement, balance sheet and cash flow

Taken from the SEC filings, converted to US dollars and normalized to actual dollars.

Q2 2026Q2 2025
Fiscal quarter22
Period start2026-04-012025-04-01
Period end2026-06-302025-06-30
Period typethree monthsthree months
Source accession6-K6-K
Non GAAP
Underlying sales growth %5.8%
Net debt29,639,668,13131,019,823,026
Underlying volume growth %5.5%
Underlying price growth %0.2%
Balance sheet
Goodwill21,138,571,52824,259,137,636
Intangible assets20,048,248,23320,515,102,081
Property plant and equipment10,681,743,19312,876,375,030
Total non current assets63,414,572,88466,864,167,190
Inventories5,162,766,4306,475,851,500
Trade and other current receivables11,646,479,5129,052,303,506
Cash and cash equivalents5,395,673,1865,112,886,026
Other current financial assets1,509,327,1161,321,770,490
Total current assets24,419,816,71222,586,621,282
Total assets87,834,389,59689,450,788,472
Current financial liabilities9,295,719,6538,421,431,749
Trade payables and other current liabilities22,047,364,55719,181,561,596
Total current liabilities32,984,848,50229,541,511,597
Non current financial liabilities27,364,260,45829,271,978,701
Total non current liabilities33,948,443,12136,450,498,930
Total liabilities66,933,291,62365,992,010,527
Shareholders equity18,488,686,32620,944,706,915
Noncontrolling interests2,412,411,6472,514,071,030
Total equity20,901,097,97323,458,777,945
Total financial liabilities36,659,980,11237,693,410,450
Segments by business group
Beauty and wellbeing
Revenue3,958,306,9193,650,851,979
Personal care
Revenue4,111,846,8883,738,182,082
Home care
Revenue3,500,013,3773,249,360,335
Foods
Revenue3,604,699,7193,614,558,949
Income statement
Revenue15,174,866,90314,252,953,345
Revenue by geographic area
Asia pacific africa6,623,155,9216,273,023,391
The americas5,893,841,0705,307,855,626
Europe2,657,869,9122,672,074,328
Conversion
CurrencyEUREUR
Closing
Eur per USD0.8758870.849618
SourceFRED DEXUSEU, rate on 2026-06-30FRED DEXUSEU, rate on 2025-06-30
Average
Eur per USD0.8597110.881712
  • Accounting basis. IAS 34 condensed interim financial statements (unaudited, furnished on Form 6-K)
  • Conversion: average source, Q2 2026. FRED DEXUSEU, average of 63 daily rates 2026-04-01 to 2026-06-30
  • Conversion: average source, Q2 2025. FRED DEXUSEU, average of 63 daily rates 2025-04-01 to 2025-06-30

UL year-to-date income statement and cash flow

Taken from the SEC filings, converted to US dollars and normalized to actual dollars.

First Half 2026 (six months ended 30 June 2026)First Half 2025 (six months ended 30 June 2025, re-presented)
Period start2026-01-012025-01-01
Period end2026-06-302025-06-30
Period typesix monthssix months
Source accession6-K6-K
Income statement
Revenue29,902,042,01727,750,517,344
Operating income5,700,795,1945,181,054,010
Net finance costs352,434,012301,375,884
Net monetary loss from hyperinflationary economies99,195,00327,199,990
Share of net profit of joint ventures and associates163,380,006158,847,939
Other income from non current investments and associates24,507,001-33,727,987
Profit before tax5,437,053,1854,977,598,089
Income tax expense1,596,456,0541,266,431,514
Net income from continuing operations3,840,597,1313,711,166,575
Net income from discontinued operations336,096,011435,199,833
Net income4,176,693,1424,146,366,408
Net income attributable to noncontrolling interests306,921,010325,311,875
Net income attributable to shareholders3,869,772,1323,821,054,533
Net income from continuing operations attributable to shareholders3,529,008,1203,399,998,694
Basic EPS1.77381.7408
Diluted EPS1.77381.7408
Diluted EPS continuing operations1.61051.5450
Basic weighted average shares2,175,100,0002,188,600,000
Diluted shares2,183,200,0002,199,600,000
Cash flow
Depreciation amortisation and impairment737,544,025702,847,730
Changes in working capital-1,436,577,049-2,640,574,986
Cash flow from continuing operating activities before tax5,072,949,1723,423,934,685
Income tax paid continuing operations-2,065,590,070-1,227,263,529
Operating cash flow3,007,359,1022,196,671,156
Total cash flows from operating activities3,003,858,1022,488,255,045
Purchase of intangible assets-92,193,003-52,223,980
Capex-620,844,021-577,727,778
Acquisition of businesses and investments in joint ventures and associates-1,011,789,034-498,303,809
Net cash used in continuing investing activities-1,213,680,041-573,375,780
Total net cash used in investing activities-779,556,027-705,023,729
Dividends paid on ordinary shares-2,372,511,081-2,430,591,067
Repurchase of shares-1,758,669,060-1,642,879,369
Net cash used in continuing financing activities-1,384,062,047-3,312,958,728
Total net cash used in financing activities-1,380,561,047-3,199,806,771
Non GAAP
Underlying operating profit6,060,231,2065,601,021,849
Underlying EPS diluted1.87891.7082
Free cash flow as defined by unilever1,807,683,0611,179,391,547
Underlying sales growth %4.8%
Underlying volume growth %4.2%
Underlying price growth %0.6%
Segments by business group
Beauty and wellbeing
Revenue7,596,003,2587,060,029,289
Operating income1,396,899,0471,156,543,556
Underlying operating profit1,480,923,0501,366,527,475
Personal care
Revenue7,955,439,2707,120,957,266
Operating income1,638,468,0561,467,711,436
Underlying operating profit1,765,671,0601,571,071,397
Home care
Revenue6,992,664,2386,423,549,533
Operating income1,081,809,037912,831,649
Underlying operating profit1,101,648,037995,519,618
Foods
Revenue7,357,935,2507,145,981,256
Operating income1,583,619,0541,643,967,369
Underlying operating profit1,711,989,0581,667,903,360
Revenue by geographic area
Asia pacific africa13,184,766,44812,403,195,237
The americas11,385,252,38710,253,308,063
Europe5,332,023,1815,094,014,044
Conversion
CurrencyEUREUR
Average
Eur per USD0.8568980.919118
Ads ratio1.01.0
  • Accounting basis. IAS 34 condensed interim financial statements (unaudited, furnished on Form 6-K)
  • Conversion: average source, First Half 2026 (six months ended 30 June 2026). Q2 2026 Form 6-K (accession 0000217410-26-000057), exchange-rate table in the non-GAAP measures section: 'US dollar (EUR1 = US$) | 1.167 | 1.088' half year average rate in 2026; expressed here as euros per US dollar (1/1.167)
  • Conversion: average source, First Half 2025 (six months ended 30 June 2025, re-presented). Q2 2026 Form 6-K (accession 0000217410-26-000057), exchange-rate table in the non-GAAP measures section: 'US dollar (EUR1 = US$) | 1.167 | 1.088' half year average rate in 2025; expressed here as euros per US dollar (1/1.088)

UL trailing twelve month income statement and cash flow

Derived by AI from the figures the filings report. No filing prints these, so none of them is linked.

Twelve months ended 30 June 2026 (derived)
Period start2025-07-01
Period end2026-06-30
Period typetrailing twelve months
Source accession6-K
Sources
FY20250000217410-26-000007
First half 2026 and 20250000217410-26-000057
Income statement
Revenue59,047,907,894
Operating income10,685,081,713
Net income from continuing operations7,107,445,729
Net income from continuing operations attributable to shareholders6,510,200,987
Non GAAP
Underlying operating profit11,815,414,047
Cash flow
Operating cash flow10,043,510,213
Conversion
CurrencyEUR
Average
Eur per USD0.85727
  • Derivation. FY2025 (Form 20-F) plus First Half 2026 less First Half 2025 (both from the Q2 2026 Form 6-K), computed in euros and then converted
  • Conversion: average source. FRED DEXUSEU, average of 250 daily rates 2025-07-01 to 2026-06-30

Adjustments

Splits appliednone
Share consolidationOn 8 December 2025 Unilever consolidated its ordinary shares, issuing 8 new shares for every 9 existing shares, alongside the demerger of its Ice Cream business. Both filings used here already restate share counts and per-share figures for every period they present as if the consolidation had taken place at the start of each period, so no further adjustment was made.
ADR ratio1
Per share basisPer-share figures are stated per American Depositary Share. The FY2025 Form 20-F states that one American Depositary Share represents one Unilever ordinary share, so the per-ADS figure equals the per-share figure before currency conversion. Share counts are weighted average ordinary share units as filed.
FXUnilever reports in euros. Every money figure is converted to US dollars: income statement, cash flow and per-share figures at the average rate for the period, balance sheet figures (and net debt) at the rate on the balance sheet date. Rates the filings state are used where they exist: 2025 annual average €1 = US$1.124 and 2024 annual average €1 = US$1.085 (FY2025 Form 20-F), First Half 2026 average €1 = US$1.167 and First Half 2025 average €1 = US$1.088 (Q2 2026 Form 6-K). The filings state no rate for 2023, for the second quarter alone, for the trailing twelve months or for any balance sheet date; those use the US Federal Reserve euro rate (FRED series DEXUSEU). Each period records the rate it was converted at under 'conversion'.

Notes

  • Sources: the annual figures come from Unilever's FY2025 Form 20-F (accession 0000217410-26-000007), which presents income statements and cash flow statements for 2025, 2024 and 2023 and balance sheets at 31 December 2025 and 2024. The interim figures come from the First Half 2026 results furnished on Form 6-K (accession 0000217410-26-000057), which presents the income statement and cash flow statement for the six months to 30 June 2026 and 2025, and balance sheets at 30 June 2026, 31 December 2025 and 30 June 2025. The 31 December 2025 balance sheet is identical in both filings and is shown once, on FY2025.
  • Unilever publishes a full income statement and cash flow statement only for the half year and the full year. For the second quarter on its own it publishes turnover (in total, by business group and by geographic area), underlying sales growth, underlying volume growth and underlying price growth, and it declares a quarterly dividend; it does not publish profit, earnings per share or cash flow for the quarter alone. The quarterly entries therefore carry turnover, its breakdowns, underlying sales, volume and price growth and the balance sheet at the quarter's end date; no second-quarter profit, earnings per share or cash flow has been derived. The first quarter of 2026 is not presented in these filings.
  • Ice Cream demerger: on 6 December 2025 Unilever demerged its Ice Cream business, now The Magnum Ice Cream Company, keeping a 19.85% stake. The 20-F restates the 2024 and 2023 income statements and cash flow statements to show Ice Cream as a discontinued operation, and the 6-K re-presents the First Half 2025 comparatives on the same basis. Balance sheets are not re-presented: the 31 December 2024 and 30 June 2025 balance sheets are as originally reported and still include the Ice Cream business, so they are not directly comparable with later dates. Net debt at 31 December 2024 is likewise not re-presented.
  • Line items: 'revenue' is the line Unilever calls Turnover; 'operating_income' is Operating profit. Cost of sales, gross profit and selling and administrative expenses come from note 3 of the 20-F and are available for the full years only; the half-year statements do not print them (the 6-K states a First Half 2026 gross margin of 46.8% in its commentary).
  • Signs: expense lines in the income statement (cost of sales, selling and administrative expenses, net finance costs, income tax expense and the net monetary loss from hyperinflationary economies) are stated as positive amounts; 'other_income_from_non_current_investments_and_associates' is signed as income, so a negative value is a loss. In the cash flow statement outflows are negative, as printed. Total financial liabilities and net debt are stated as positive amounts (the reconciliations print them as negatives).
  • Earnings per share: 'diluted_eps' is diluted earnings per share for total operations, including discontinued operations, and 'diluted_eps_continuing_operations' excludes them. Unilever's headline GAAP measure is the continuing-operations figure (€1.38 for First Half 2026, down 2.5%). FY2025 total earnings include a €3,373 million gain on disposal of discontinued operations (the gain on the Ice Cream demerger, note 21 of the 20-F), and First Half 2026 includes a €299 million gain on the sale of the India and Portugal ice cream businesses to The Magnum Ice Cream Company.
  • Cash flow: 'operating_cash_flow' is net cash flow from continuing operating activities, after income tax paid. Unilever's own 'cash flow from operating activities', which its free cash flow definition starts from, is before income tax paid and is shown separately as 'cash_flow_from_continuing_operating_activities_before_tax'. 'capex' is purchases of property, plant and equipment only; purchases of intangible assets are shown separately. No free cash flow is computed here; Unilever's own free cash flow (cash flow from operating activities less income taxes paid, net capital expenditure and net interest payments) is shown in the non-GAAP block.
  • The 'non_gaap' block holds Unilever's own underlying measures, each reconciled in the filings: underlying operating profit (Unilever's segment profit measure), underlying earnings per share (diluted), free cash flow, net debt, underlying sales growth and its two components, underlying volume growth and underlying price growth. They are not IFRS measures.
  • Segments: business-group figures cover Beauty & Wellbeing, Personal Care, Home Care and Foods (turnover, operating profit and underlying operating profit for the full years and the half years; turnover only for the second quarters). Geographic turnover covers Asia Pacific Africa, The Americas and Europe.
  • The trailing twelve months to 30 June 2026 are derived as FY2025 plus First Half 2026 less First Half 2025, computed in euros from the figures above and then converted at the average rate for those twelve months. All three periods are on the continuing-operations basis that excludes Ice Cream.
  • At 30 June 2026 the balance sheet prints shareholders' equity of €16,194 million and the statement of changes in equity €16,193 million, a rounding difference; the balance sheet figure is used.
  • The Board declared a second-quarter 2026 dividend of €0.4664 per ordinary share; the 6-K states the amount payable per American Depositary Receipt as US$0.5305, determined using exchange rates on 24 July 2026.

Uncertainties

  • No exchange rate is stated in the filings for the second quarter alone, for 2023, for the trailing twelve months or for any balance sheet date, so those periods are converted at US Federal Reserve rates. The half-year figures use the company's stated half-year average rate, so a second-quarter dollar figure is not an exact share of the half-year dollar figure.
  • The trailing-twelve-month figures combine audited full-year 2025 figures with unaudited interim figures; they are derived here and are not printed in any filing.
  • Balance sheets at 31 December 2024 and 30 June 2025 include the Ice Cream business, which was demerged in December 2025; changes in balance sheet items across those dates reflect the demerger as well as trading.

Company details

NameUnilever Plc
TickerUL
CIK0000217410
ExchangeNYSE
State
CountryUnited Kingdom
Incorporation
SIC2840
OfficeIndustrial Applications and Services
IndustrySoap, Detergents, Cleang Preparations, Perfumes, Cosmetics

Fiscal period

Fiscal year2026
Fiscal periodQ2
TagFY26Q2
Period end2026-06-30
Form6-K
Accession0000217410-26-000057
Fiscal year end1231
Sourcederived

Source filings

RoleCurrentFormFiscal yearFiscal periodTagPeriod endFiledAccessionSource
annualno20-F2025FYFY252025-12-312026-03-120000217410-26-000007reported
quarterlyyes6-K2026Q2FY26Q22026-06-302026-07-280000217410-26-000057derived

Related companies

See every covered company and its filings data.

Not investment advice, see the Disclaimer.